By itself, use of electronic health records (EHRs) does not improve the quality of care for heart failure, says Mary Norine Walsh, MD.
By itself, use of electronic health records (EHRs) does not improve the quality of care for heart failure, says Mary Norine Walsh, MD.
In a national study, outpatient cardiology practices that used EHRs performed no better on six of seven care measures than those that did not use EHRs.
Seven quality-of-care measures were compared between 87 sites that used electronic health records (50 used them exclusively, 37 used a combination of electronic and paper records) and 80 sites that used paper records only. The seven measures were all evidence-based guideline-recommended practices:
Only the use of aldosterone-receptor blockers in appropriate patients and the provision of heart failure education were significantly more common among the sites that used EHRs compared with the sites that did not. When adjusted for practice characteristics, only the provision of heart failure education remained significantly better among the sites that adopted electronic records.
“These observations are consistent with a recent 2008 Health Information Technology in the United States [study] that found no significant association between electronic health record use and quality of care,” says Dr. Walsh, a cardiologist and director of nuclear cardiology and congestive heart failure at St. Vincent Hospital in Indianapolis. Performance improvement interventions may also be needed in addition to electronic records to influence quality of care and clinical outcomes, she adds.
Iowa Expands PBM Legislation to Address Concerns of Independent Pharmacies
May 16th 2025A new law in Iowa, if signed by the governor, will mandate 100% pass-through of rebates, increased financial transparency, and a minimal payment for pharmacies. Critics say it will be the most costly mandate in the state’s history.
Read More
Is Arkansas’ New PBM Law the Right Path Forward for Reform? No One Knows Yet
May 9th 2025It could improve access to community pharmacies and lower prices. Or it will limit access to critical drugs and impact payers’ ability to contract for a broad range of services. Industry leaders are unsure about the impact of Arkansas’ law banning PBMs from owning pharmacies.
Read More